NDC 80425-0042-01 - Meloxicam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0042
- Requested NDC
- 80425-0042-01
- Package NDCs from labels
- 80425-0042-3, 80425-0042-2, 80425-0042-1, 80425-0042-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Meloxicam - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0042-1 | Meloxicam | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 80425-0042-2 | Meloxicam | 60 in 1 BOTTLE | TABLET | 60 | 7 | |
| 80425-0042-3 | Meloxicam | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0042 | MELOXICAM TABLET [ADVANCED RX OF TENNESSEE, LLC] | 7 | Current NDC, Legacy NDC, 3 package rows | 20250101_af9cf496-d505-f2ba-e053-2995a90a76cf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0042-1 | EA - Each | 80425-0042 | 97a0a1f4-6aba-41a2-96d6-daeb4bde3e02 | 1 | 2023-06-06 |
| 80425-0042-2 | EA - Each | 80425-0042 | c5fd26d3-2cb2-4f5e-853b-47edc87a8384 | 1 | 2023-06-06 |
| 80425-0042-3 | EA - Each | 80425-0042 | c1d07278-504c-479c-9852-2343c7726ee7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 9392df66-a152-40e6-b43b-44dc46a23496 | 2021-08-10 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 10c3949c-0066-4b8a-8d35-937e1ce09bf8 | 2021-08-06 | Boxed warning, Warnings, Adverse reactions | ANDA077921 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 8f43b954-d1cb-4210-b479-5292c446cc74 | 2021-05-20 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 966ae650-ad7d-4de1-ab06-54992408fcfd | 2021-03-11 | Boxed warning, Warnings, Adverse reactions | ANDA077921 311486 VG2QF83CGL |
| Meloxicam | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2a29daa9-74e5-4ed6-b5f1-ce04dc411b26 | 2020-07-20 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Exelan Pharmaceuticals Inc. | dfaac71c-dcc5-4b57-bf3b-616fccab96de | 2018-09-19 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.